Search

01/06/2024 CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas
Virgili, AC, Salazar, J, Gallardo, A, López-Pousa, A, Terés, R, Bagué, S, Orellana, R, Fumagalli, C, Mangues, R, Alba-Castellón, L, Unzueta, U, Casanova, I, Sebio, A. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 2024; 14(11)DOI:10.3390/diagnostics14111195. PMID:38893721. IF:3.300(Q1/2D).
01/06/2024 Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis
Cullell, BM, Manrique, ACV, Piedra, A, Fumagalli, C, Mateo, FJP, Serda, PC, Mirallas, O, Martínez, E, Trujillo, JC, Belda-Sanchis, J, Szafranska, J, Paez, D. Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.133. PMID:. IF:65.400(Q1/1D).
01/04/2024 RET Fusion Testing in Patients With NSCLC: The RETING Study
Conde, E, Hernandez, S, Carrillo, JLR, Martinez, R, Alonso, M, Curto, D, Jimenez, B, Caminoa, A, Benito, A, Garrido, P, Clave, S, Arriola, E, Esteban-Rodriguez, I, De Castro, J, Sansano, I, Felip, E, Rojo, F, Dómine, M, Abdulkader, I, Garcia-Gonzalez, J, Teixido, C, Reguart, N, Compañ, D, Insa, A, Mancheño, N, Palanca, S, Juan-Vidal, O, Baixeras, N, Nadal, E, Cebollero, M, Calles, A, Martin, P, Salas, C, Provencio, M, Aranda, I, Massuti, B, Lopez-Vilaro, L, Majem, M, Paz-Ares, L, Lopez-Rios, F. RET Fusion Testing in Patients With NSCLC: The RETING Study. Jto Clinical And Research Reports. 2024; 5(4)DOI:10.1016/j.jtocrr.2024.100653. PMID:38525319. IF:(Q/D).
10/03/2024 Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Gronchi, A, Palmerini, E, Quagliuolo, V, Broto, JM, Pousa, AL, Grignani, G, Brunello, A, Blay, JY, Tendero, O, Beveridge, RD, Ferraresi, V, Lugowska, I, Pizzamiglio, S, Verderio, P, Fontana, V, Donati, DM, Palassini, E, Sanfilippo, R, Bianchi, G, Bertuzzi, A, Morosi, C, Pasquali, S, Stacchiotti, S, Bagué, S, Coindre, JM, Miceli, R, Dei Tos, AP, Casali, PG. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(8)DOI:10.1200/JCO.23.00908. PMID:38232337. IF:41.900(Q1/1D).
01/03/2024 Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy
Arqueros, C, Gallardo, A, Vidal, S, Osuna-Gómez, R, Tibau, A, Bell, OL, Cajal, T, Lerma, E, Lobato-Delgado, B, Salazar, J, Barnadas, A. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(5)DOI:10.3390/ijms25052627. PMID:38473874. IF:4.900(Q1/3D).
01/03/2024 A Clinicopathologic and Immunohistochemical Analysis of 46 Uterine Mesenchymal Tumors Including Conventional Adenosarcomas, Atypical Uterine Polyps and Other Related Sarcomas
Angelo, ED, Espinosa, I, Wang, AH, Kingsley, L, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. A Clinicopathologic and Immunohistochemical Analysis of 46 Uterine Mesenchymal Tumors Including Conventional Adenosarcomas, Atypical Uterine Polyps and Other Related Sarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).